Methods for Fully Segregating Recombinant Marine Cyanobacteria
AssigneeAlgenol Biofuels Inc.
InventorsMing-De Deng, Alexandra Friedrich, Kerstin Baier, Nien-Hsi Ko
Life of this patent
Estimating the term…
Abstract
Methods and compositions are provided for the full segregation of recombinant marine cyanobacteria.
Claims36
A method for isolating recombinant marine cyanobacteria containing a recombinant form of a high copy number endogenous plasmid and lacking the wild-type form of said high copy number endogenous plasmid, said recombinant form of said high copy number endogenous plasmid comprising a wild-type high copy number endogenous plasmid backbone and an exogenous polynucleotide sequence insert, said exogenous polynucleotide sequence insert comprising a selective marker, said method comprising:
- a) culturing a recombinant marine cyanobacteria comprising said recombinant form of said high copy number endogenous plasmid on low salt media comprising concentrations of a selective agent,
- b) analyzing plasmid DNA from colonies cultured on a medium of step a) for the presence of said recombinant form of said high copy number endogenous plasmid and for the absence of said wild-type high copy number endogenous plasmid, and
- c) isolating recombinant marine cyanobacteria from step b) that contain copies of said recombinant form of said high copy number endogenous plasmid and do not contain said wild-type high copy number endogenous plasmid.
A method for isolating recombinant Synechococcus sp. strain PCC 7002 containing a recombinant form of a high copy number endogenous plasmid and lacking the wild-type form of said high copy number endogenous plasmid, said recombinant form of a high copy number endogenous plasmid comprising a wild-type high copy number endogenous plasmid backbone and an exogenous polynucleotide sequence insert, said exogenous polynucleotide sequence insert comprising a selective marker, said method comprising:
- a) transforming Synechococcus sp. strain PCC 7002 comprising said wild-type high copy number endogenous plasmid with an exogenous polynucleotide,
- b) culturing said transformed Synechococcus sp. strain PCC 7002 in media comprising a selective agent,
- c) culturing said cultured transformed Synechococcus sp. strain PCC 7002 from step b) on low salt media comprising concentrations of a selective agent,
- d) selecting individual colonies from a medium of step c),
- e) culturing said selected individual colonies from step d) on said medium of step d),
- f) selecting colonies from said medium of step e),
- g) culturing said selected colonies from step f) on a high salt medium,
- h) analyzing plasmid DNA from said high salt medium cultures from step g) for the presence of said recombinant form of a high copy number endogenous plasmid and for the absence of said wild-type high copy number endogenous plasmid,
- i) isolating recombinant Synechococcus sp. strain PCC 7002 from step h) that contain copies of said recombinant form of a high copy number endogenous plasmid and do not contain said wild-type high copy number endogenous plasmid, and
- j) culturing said isolated recombinant Synechococcus sp. strain PCC 7002 from step i) in a high salt medium that does not contain said selective agent for a period of time.
A genetically-modified Synechococcus sp. strain PCC 7002 host cell comprising a recombinant form of a high copy number endogenous plasmid, wherein no corresponding high copy number endogenous plasmid is present in said host cell.
Dependencies are inferred from the claim text.